What is
Cell Salvage?
Discover how intraoperative cell salvage technology revolutionises patient care by collecting, processing, and returning a patient’s own blood during surgical procedures.
90%
Reduction in allogeneic transfusion
Zero
Disease transmission risk
50%
Faster recovery times
Clinical Benefits Matter
Intraoperative Cell Salvage represents a paradigm shift in surgical blood management, offering clinically proven benefits that extend far beyond simple blood conservation.
Intraoperative cell salvage, also known as autotransfusion, is the collection of a patient’s own blood lost during surgical procedures. The blood is collected, processed through advanced washing systems, and the concentrated red cells are reinfused back to the patient.
This innovative technology represents a safe and effective alternative to donor blood transfusion, significantly reducing the risks associated with allogeneic blood while ensuring patients receive their own healthy red blood cells during surgery.
Key Clinical Impact Areas
Patient Safety & Risk Reduction
Complete elimination of transfusion reactions and disease transmission
Surgical Outcomes & Recovery
50% faster recovery times with improved patient satisfaction
Resource Optimization
Enhanced bed turnover and reduced healthcare costs
Quality of Care Enhancement
Superior patient outcomes across all surgical specialties
Primary Clinical Benefits
Evidence-based advantages that transform patient care and surgical outcomes through proven clinical benefits and superior patient safety profiles.
No Transfusion Reactions
Perfect compatibility with zero incompatibility risk, no allergic reactions, and immediate availability of fresh, warm autologous blood.
Zero Risk
Perfect Match
Immediate Use
Clinical Impact
Eliminates ABO incompatibility reactions
Prevents allergic transfusion reactions
Reduces ICU monitoring requirements
Improves surgical workflow efficiency
Universal Acceptance
Continuous circuit principle compliance
No external blood storage required
Expands treatment options for all patients
Respects religious and ethical beliefs
Religious & Cultural Compliance
Acceptable to Jehovah’s Witnesses through continuous circuit principle, with no external storage, respecting religious beliefs and expanding treatment options.
Continuous Circuit
Ethical Solution
Universal Access
Accelerated Recovery
Patients experience 2-3 days earlier discharge, faster mobilization, improved bed turnover, and enhanced satisfaction with quicker return to normal life.
2-3 Days Earlier
Faster Mobility
Better Satisfaction
Recovery Benefits
Reduced hospital length of stay
Earlier mobilization and rehabilitation
Improved patient satisfaction scores
Enhanced quality of life outcomes
Zero Disease Transmission
Complete elimination of blood-borne pathogen risks including HIV, Hepatitis B/C, prion diseases, and protection against future unknown pathogens.
Preserved Immune Function
60% reduction in infections with no immunosuppressive effects, enhanced wound healing, and improved survival rates.
Complex Cases Solution
Perfect for patients with multiple alloantibodies, rare blood types, emergency situations, and massive transfusion requirements.
Research Evidence & Clinical Studies
Comprehensive research demonstrates the clinical effectiveness of cell salvage across multiple surgical specialties with robust evidence from systematic reviews and large-scale studies.
Cochrane Systematic Review
Comprehensive analysis of 75 randomized controlled trials involving over 7,000 patients demonstrates significant reduction in allogeneic blood transfusion requirements.
42%
Reduction in Transfusions
Level I
Evidence Quality
Infection Risk Studies
Large-scale studies in cardiac and orthopedic surgery show significant reduction in post-operative infections when cell salvage is used versus allogeneic transfusion.
42%
Reduction in Transfusions
Level I
Evidence Quality
Health Economic Analysis
42%
Reduction in Transfusions
Level I
Evidence Quality
Key Research Findings
Clinical Outcomes
Transfusion Reduction
40-60% decrease in allogeneic blood requirements across surgical specialties
Infection Prevention
Significant reduction in post-operative infection rates and complications
Recovery Enhancement
Faster recovery times and improved patient satisfaction scores
Quality Evidence
Systematic Reviews
Multiple Cochrane reviews confirm consistent clinical benefits
Randomized Trials
Over 100 RCTs demonstrate safety and effectiveness
Long-term Studies
Sustained benefits with excellent long-term outcomes
The Clear Choice for Patient Care
Cell salvage delivers superior clinical outcomes, enhanced patient safety, and significant cost savings compared to traditional allogeneic blood transfusion across all measures of success.